BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 2528593)

  • 1. Induction of activation antigens on human natural killer cells mediated through the Fc-gamma receptor.
    Harris DT; Travis WW; Koren HS
    J Immunol; 1989 Oct; 143(7):2401-6. PubMed ID: 2528593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of cloned human natural killer cells via Fc gamma RIII.
    Werfel T; Uciechowski P; Tetteroo PA; Kurrle R; Deicher H; Schmidt RE
    J Immunol; 1989 Feb; 142(4):1102-6. PubMed ID: 2464637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of CD16 (Fc receptor III) and interleukin-2 in the reactivation of natural killer cells after inhibitory target cell contact.
    Heiskala M; Ståhls A; Seppälä I; Timonen T
    Nat Immun Cell Growth Regul; 1991; 10(5):265-77. PubMed ID: 1836835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transient activation of the NADPH oxidase through Fc gamma RI. Oxidase deactivation precedes internalization of cross-linked receptors.
    Pfefferkorn LC; Fanger MW
    J Immunol; 1989 Oct; 143(8):2640-9. PubMed ID: 2551966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of anti-IgM and growth factor-induced proliferation of guinea pig B cells by one of two distinct Fc gamma receptors on the cells.
    Yamashita T; Koyama J
    J Immunol; 1988 Nov; 141(9):2889-94. PubMed ID: 2971734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The low affinity 40,000 Fc gamma receptor and the transferrin receptor can be alternative or simultaneous target structures on cells sensitive for natural killing.
    Perl A; Looney RJ; Ryan DH; Abraham GN
    J Immunol; 1986 Jun; 136(12):4714-20. PubMed ID: 3011902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of cytolytic activity in CD3- and CD3+ killer cell clones by monoclonal antibodies (anti-CD16, anti-CD2, anti-CD3) depends on subclass specificity of target cell IgG-FcR.
    van de Griend RJ; Bolhuis RL; Stoter G; Roozemond RC
    J Immunol; 1987 May; 138(10):3137-44. PubMed ID: 2952709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant interleukin 2 enhanced natural killer cell-mediated cytotoxicity in human lymphocyte subpopulations expressing the Leu 7 and Leu 11 antigens.
    Lanier LL; Benike CJ; Phillips JH; Engleman EG
    J Immunol; 1985 Feb; 134(2):794-801. PubMed ID: 3871216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphokine-activated killer activity induced by in vivo interleukin 2 therapy: predominant role for lymphocytes with increased expression of CD2 and leu19 antigens but negative expression of CD16 antigens.
    Weil-Hillman G; Fisch P; Prieve AF; Sosman JA; Hank JA; Sondel PM
    Cancer Res; 1989 Jul; 49(13):3680-8. PubMed ID: 2471587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T cell unresponsiveness to the mitogenic activity of OKT3 antibody results from a deficiency of monocyte Fc gamma receptors for murine IgG2a and inability to cross-link the T3-Ti complex.
    Ceuppens JL; Bloemmen FJ; Van Wauwe JP
    J Immunol; 1985 Dec; 135(6):3882-6. PubMed ID: 2933454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the Fc mu receptor on human natural killer cells. Interaction with its physiologic ligand, human normal IgM, specificity of binding, and functional effects.
    Pricop L; Rabinowich H; Morel PA; Sulica A; Whiteside TL; Herberman RB
    J Immunol; 1993 Sep; 151(6):3018-29. PubMed ID: 7690792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transmembrane signaling during natural killer cell-mediated cytotoxicity. Regulation by protein kinase C activation.
    Leibson PJ; Midthun DE; Windebank KP; Abraham RT
    J Immunol; 1990 Sep; 145(5):1498-504. PubMed ID: 2166762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of interleukin 2 and T11 E rosette antigen in activation and proliferation of human NK clones.
    Schmidt RE; Hercend T; Fox DA; Bensussan A; Bartley G; Daley JF; Schlossman SF; Reinherz EL; Ritz J
    J Immunol; 1985 Jul; 135(1):672-8. PubMed ID: 3923116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of Fc gamma receptor IIIA alpha (CD16-II) on natural killer cells induced by anti-CD16 mAb is independent of protein tyrosine kinases and protein kinase C.
    Borrego F; Lopez-Beltran A; Peña J; Solana R
    Cell Immunol; 1994 Oct; 158(1):208-17. PubMed ID: 8087866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypic analysis of a resting subpopulation of human peripheral blood NK cells: the FcR gamma III (CD16) molecule and NK cell differentiation.
    Warren HS; Skipsey LJ
    Immunology; 1991 Jan; 72(1):150-7. PubMed ID: 1825480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional and biochemical analysis of CD16 antigen on natural killer cells and granulocytes.
    Lanier LL; Ruitenberg JJ; Phillips JH
    J Immunol; 1988 Nov; 141(10):3478-85. PubMed ID: 2903193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-4 (B cell stimulatory factor 1) overcomes Fc gamma receptor-mediated inhibition of mouse B lymphocyte proliferation without affecting inhibition of c-myc mRNA induction.
    Phillips NE; Gravel KA; Tumas K; Parker DC
    J Immunol; 1988 Dec; 141(12):4243-9. PubMed ID: 2974056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of Fc receptor (CD16) ligands induces transcription of interleukin 2 receptor (CD25) and lymphokine genes and expression of their products in human natural killer cells.
    Anegón I; Cuturi MC; Trinchieri G; Perussia B
    J Exp Med; 1988 Feb; 167(2):452-72. PubMed ID: 2831292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural killer cell and granulocyte Fc gamma receptor III (CD16) differ in membrane anchor and signal transduction.
    Selvaraj P; Carpén O; Hibbs ML; Springer TA
    J Immunol; 1989 Nov; 143(10):3283-8. PubMed ID: 2553809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative studies of human FcRIII-positive and negative natural killer cells.
    Nagler A; Lanier LL; Cwirla S; Phillips JH
    J Immunol; 1989 Nov; 143(10):3183-91. PubMed ID: 2530273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.